Psychopharmacology and Psychiatry Updates

Ein Podcast von Psychopharmacology Institute

Kategorien:

213 Folgen

  1. Balancing Benefits and Risks: Antipsychotics in Hepatic Dysfunction

    Vom: 25.6.2024
  2. Insomnia and Depression: A Tangled Web

    Vom: 20.6.2024
  3. ADHD Treatment During Pregnancy: Insights from Denmark

    Vom: 15.6.2024
  4. The Power of Nonpharmacologic Therapies in Fibromyalgia

    Vom: 10.6.2024
  5. Highlights From APA 2024: Key Insights on Psychopharmacology

    Vom: 5.6.2024
  6. Antidepressants in Pregnancy: Weighing the Evidence

    Vom: 31.5.2024
  7. Unraveling the Pharmacological Puzzle of Fibromyalgia

    Vom: 26.5.2024
  8. Weighing the Evidence: Antipsychotics in Pediatric Anorexia Nervosa

    Vom: 21.5.2024
  9. Beyond the Pain: Diagnosing Fibromyalgia

    Vom: 17.5.2024
  10. Informed Consent and SSRIs: Discussing the Risk of Irreversible Sexual Side Effects

    Vom: 11.5.2024
  11. Mastering Clozapine: Adverse Effect Management

    Vom: 6.5.2024
  12. Preventing Depression and Anxiety Relapse in Youth

    Vom: 1.5.2024
  13. Charting the Clozapine Course: Titration and Monitoring

    Vom: 26.4.2024
  14. Smoking and Psychosis: Insights from the PATH Study

    Vom: 21.4.2024
  15. Clozapine: The Gold Standard for Treatment-Resistant Schizophrenia

    Vom: 16.4.2024
  16. Balancing Benefits and Risks: Lithium in Child and Adolescent Psychiatry

    Vom: 11.4.2024
  17. Orchestrating Nutrition and Medication: Micronutrient Therapy in Practice

    Vom: 6.4.2024
  18. Zuranolone: A New Dawn for Postpartum Depression Treatment

    Vom: 1.4.2024
  19. Micronutrients for Psychiatric Disorders: Optimizing Clinical Use

    Vom: 27.3.2024
  20. Olanzapine in Pregnancy: Examining the Risks

    Vom: 22.3.2024

1 / 11

Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.

Visit the podcast's native language site